Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs

Virus Research

Volumn 167, Issue 2, 2012, Pages 188-195

  Xu, Jiarong ^a   Huang, Dongyan ^a,b   Liu, Shichao ^a   Lin, Huixing ^a   Zhu, Haodan ^a   Liu, Bao ^a   Lu, Chengping ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b JIANGXI AGRICULTURAL UNIVERSITY   (China)

Author keywords

Animal trial; Hemagglutinin; Immunogenicity; Protection efficacy; Recombinant swinepox virus; Swine H3N2 influenza virus

Indexed keywords

GAMMA INTERFERON; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; IMMUNE RESPONSE; INFLUENZA VIRUS A H3N2; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUIPOXVIRUS; T LYMPHOCYTE; VACCINATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DRUG CARRIERS; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SUIPOXVIRUS; SWINE; T-LYMPHOCYTES; VACCINATION; VACCINES, SYNTHETIC; VIRUS SHEDDING;

ANIMALIA; MUS; ORTHOMYXOVIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS; SUIDAE; SWINE INFLUENZA VIRUS; SWINEPOX VIRUS; SWINEPOX VIRUS (STRAIN KASZA);

EID: 84863882518     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.04.014     Document Type: Article

References (46)

1. Barcena J., Blasco R. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture. Virology 1998, 243(2):396-405.
2. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31(2 Pt 1):417-427.
3. Chen H., Huang Q., Cui B., Li X., Guan Q. Construction of recombinant fowlpox virus coexpressing HA from subtype H5 of avian influenza virus and chicken interleukin-18. Wei Sheng Wu Xue Bao 2008, 48(8):1025-1030.
4. Du Y., Li Y., He H., Qi J., Jiang W., Wang X., Tang B., Cao J., Wang X., Jiang P. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine. Journal of Virological Methods 2008, 149(1):144-152.
5. Ducatez M.F., Webster R.G., Webby R.J. Animal influenza epidemiology. Vaccine 2008, 26(Suppl. 4):D67-D69.
6. Fitzpatrick E.A., Avdiushko M., Kaplan A.M., Cohen D.A. Role of T cell subsets in the development of AIDS-associated interstitial pneumonitis in mice. Experimental Lung Research 1999, 25(8):671-687.
7. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
8. Hahn J., Park S.H., Song J.Y., An S.H., Ahn B.Y. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein. Journal of Virological Methods 2001, 93(1-2):49-56.
9. Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A., Bianchi A.T. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. Journal of General Virology 2002, 83(Pt 8):1851-1859.
10. Hel Z., Tsai W.P., Thornton A., Nacsa J., Giuliani L., Tryniszewska E., Poudyal M., Venzon D., Wang X., Altman J., Watkins D.I., Lu W., von Gegerfelt A., Felber B.K., Tartaglia J., Pavlakis G.N., Franchini G. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. Journal of Immunology 2001, 167(12):7180-7191.
11. Hessel A., Schwendinger M., Holzer G.W., Orlinger K.K., Coulibaly S., Savidis-Dacho H., Zips M.L., Crowe B.A., Kreil T.R., Ehrlich H.J., Barrett P.N., Falkner F.G. Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity. PLoS One 2011, 6(1):e16247.
12. Hghihghi H.R., Read L.R., Mohammadi H., Pei Y., Ursprung C., Nagy E., Behboudi S., Haeryfar S.M., Sharif S. Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus. Clinical and Vaccine Immunology 2011, 17(3):454-463.
13. Ito T. Interspecies transmission and receptor recognition of influenza A viruses. Microbiology and Immunology 2000, 44(6):423-430.
14. Jacobs B.L., Langland J.O., Kibler K.V., Denzler K.L., White S.D., Holechek S.A., Wong S., Huynh T., Baskin C.R. Vaccinia virus vaccines: past, present and future. Antiviral Research 2009, 84(1):1-13.
15. Jin H.S., Park E.K., Lee J.M., NamKoong S.E., Kim D.G., Lee Y.J., Jun H.J., Han B.D., Bae S.M., Ahn W.S. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor. Gynecologic Oncology 2005, 97(2):559-567.
16. Khurana S., Larkin C., Verma S., Joshi M.B., Fontana J., Steven A.C., King L.R., Manischewitz J., McCormick W., Gupta R.K., Golding H. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine 2011, 29(34):5657-5665.
17. Kreijtz J.H., Suezer Y., de Mutsert G., van Amerongen G., Schwantes A., van den Brand J.M., Fouchier R.A., Lower J., Osterhaus A.D., Sutter G., Rimmelzwaan G.F. MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. PLoS One 2009, 4(11):e7790.
18. Kreijtz J.H., Suezer Y., de Mutsert G., van den Brand J.M., van Amerongen G., Schnierle B.S., Kuiken T., Fouchier R.A., Lower J., Osterhaus A.D., Sutter G., Rimmelzwaan G.F. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. Journal of Infectious Diseases 2009, 199(3):405-413.
19. Kyriakis C.S., De Vleeschauwer A., Barbe F., Bublot M., Van Reeth K. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 2009, 27(16):2258-2264.
20. Larsen D.L., Karasin A., Zuckermann F., Olsen C.W. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Veterinary Microbiology 2000, 74(1-2):117-131.
21. Li J., Jiang P., Li Y., Wang X., Cao J., Wang X., Zeshan B. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs. Vaccine 2009, 27(6):825-832.
22. Lin H.X., Huang D.Y., Wang Y., Lu C.P., Fan H.J. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein. Vaccine 2011, 29(40):7027-7034.
23. Manicassamy B., Medina R.A., Hai R., Tsibane T., Stertz S., Nistal-Villan E., Palese P., Basler C.F., Garcia-Sastre A. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathogens 2011, 6(1):e1000745.
24. Masic A., Booth J.S., Mutwiri G.K., Babiuk L.A., Zhou Y. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. Journal of Virology 2009, 83(19):10198-10210.
25. Masic A., Lu X., Li J., Mutwiri G.K., Babiuk L.A., Brown E.G., Zhou Y. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 2011, 28(43):7098-7108.
26. Moorkamp L., Beineke A., Kaim U., Diesterbeck U., Urstadt S., Czerny C.P., Ruberg H., Grosse Beilage E. Swinepox-skin disease with sporadic occurrence. Dtsch Tierarztl Wochenschr 2008, 115(4):162-166.
27. Park E.K., Kim Y.W., Lee J.M., NamKoong S.E., Kim D.G., Chun H.J., Han B.D., Bae S.M., Jin H.S., Sin J.I., Ahn W.S. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity against human papillomavirus 16-associated tumor. Cancer Research Treatment 2005, 37(1):63-70.
28. Purdy A., Case L., Duvall M., Overstrom-Coleman M., Monnier N., Chervonsky A., Golovkina T. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies. Journal of Experimental Medicine 2003, 197(2):233-243.
29. Ryman K.D., White L.J., Johnston R.E., Klimstra W.B. Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunology 2002, 15(1):53-76.
30. Shortridge K.F., Webster R.G., Butterfield W.K., Campbell C.H. Persistence of Hong Kong influenza virus variants in pigs. Science 1977, 196(4297):1454-1455.
31. Tang M., Harp J.A., Wesley R.D. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Archives of Virology 2002, 147(11):2125-2141.
32. Tian Z.J., Zhou G.H., Zheng B.L., Qiu H.J., Ni J.Q., Yang H.L., Yin X.N., Hu S.P., Tong G.Z. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Veterinary Immunology and Immunopathology 2006, 111(3-4):211-218.
33. Tripathy D.N. Swinepox virus as a vaccine vector for swine pathogens. Advances in Veterinary Medicine 1999, 41:463-480.
34. van der Leek M.L., Feller J.A., Sorensen G., Isaacson W., Adams C.L., Borde D.J., Pfeiffer N., Tran T., Moyer R.W., Gibbs E.P. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Veterinary Record 1994, 134(1):13-18.
35. Van Reeth K., Braeckmans D., Cox E., Van Borm S., van den Berg T., Goddeeris B., De Vleeschauwer A. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine 2009, 27(45):6330-6339.
36. Veits J., Romer-Oberdorfer A., Helferich D., Durban M., Suezer Y., Sutter G., Mettenleiter T.C. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 2008, 26(13):1688-1696.
37. Wang T.T., Palese P. Unraveling the mystery of swine influenza virus. Cell 2009, 137(6):983-985.
38. Webby R.J., Swenson S.L., Krauss S.L., Gerrish P.J., Goyal S.M., Webster R.G. Evolution of swine H3N2 influenza viruses in the United States. Journal of Virology 2000, 74(18):8243-8251.
39. Webster R.G., Sharp G.B., Claas E.C. Interspecies transmission of influenza viruses. American Journal of Respiratory and Critical Care Medicine 1995, 152(4 Pt 2):S25-S30.
40. Wesley R.D., Tang M., Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 2004, 22(25-26):3427-3434.
41. Weyer J., Rupprecht C.E., Nel L.H. Poxvirus-vectored vaccines for rabies-a review. Vaccine 2009, 27(51):7198-7201.
42. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289(5796):373-378.
43. Winslow B.J., Cochran M.D., Holzenburg A., Sun J., Junker D.E., Collisson E.W. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin. Virus Research 2003, 98(1):1-15.
44. Winslow B.J., Kalabat D.Y., Brown S.M., Cochran M.D., Collisson E.W. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants. Veterinary Microbiology 2005, 111(1-2):1-13.
45. Yu H., Hua R.H., Zhang Q., Liu T.Q., Liu H.L., Li G.X., Tong G.Z. Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006. Journal of Clinical Microbiology 2008, 46(3):1067-1075.
46. Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., Liu L., Yoon K., Krauss S., Webster R.G. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. Journal of Virology 1999, 73(10):8851-8856.